AEterna Zentaris (TSX:AEZS) Dividend Yield % : 0.00% (As of Apr. 26, 2024)

View and export this data going back to 1995. Start your Free Trial

What is AEterna Zentaris Dividend Yield %?

As of today (2024-04-26), the Trailing Annual Dividend Yield of AEterna Zentaris is 0.00%.

The historical rank and industry rank for AEterna Zentaris's Dividend Yield % or its related term are showing as below:

TSX:AEZS's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.59
* Ranked among companies with meaningful Dividend Yield % only.

AEterna Zentaris's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00.

As of today (2024-04-26), the Forward Dividend Yield % of AEterna Zentaris is 0.00%.

AEterna Zentaris's Dividends per Share for the three months ended in Dec. 2023 was C$0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of AEterna Zentaris was -6.70% per year. The lowest was -6.70% per year. And the median was -6.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

AEterna Zentaris Dividend Yield % Historical Data

The historical data trend for AEterna Zentaris's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris Dividend Yield % Chart

AEterna Zentaris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Yield %

Get a 7-Day Free Trial

AEterna Zentaris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividend Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of AEterna Zentaris's Dividend Yield %

For the Biotechnology subindustry, AEterna Zentaris's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AEterna Zentaris's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEterna Zentaris's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where AEterna Zentaris's Dividend Yield % falls into.

AEterna Zentaris Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

AEterna Zentaris (TSX:AEZS) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

AEterna Zentaris Dividend Yield % Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

AEterna Zentaris (TSX:AEZS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (TSX:AEZS) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

AEZS:USA ET8:Germany

Address

222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.